Medicare Enrolled

Dr. Sukhchain Samra, NP

Physician Assistant · Bakersfield, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8605 CAMINO MEDIA STE 300, Bakersfield, CA 93311
6613222700
In practice since 2017 (8 years)
NPI: 1073032447 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Samra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Samra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Samra

Dr. Sukhchain Samra is a physician assistant in Bakersfield, CA, with 8 years of NPI registration. Based on federal Medicare data, Dr. Samra performed 1,754 Medicare services across 604 unique beneficiaries.

Between the years covered by Open Payments, Dr. Samra received a total of $6,715 from 23 pharmaceutical and/or device companies across 255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Samra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice ▲ Top 6% volume in CA $6,715 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,754
Medicare services
Top 6% in CA for physician assistant
604
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~219 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
803 $5 $20
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
284 $56 $241
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
136 $31 $190
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
119 $71 $325
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
106 $55 $290
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
102 $36 $145
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
73 $61 $301
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
63 $112 $475
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters.
34 $54 $350
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
34 $36 $151
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,715
Total received (2021-2024)
Avg $1,679/year across 4 years
Top 4% in CA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
255
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,578 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$137 (2.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,907
2023
$2,402
2022
$1,027
2021
$378

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$678
ABBVIE INC.
$581
Janssen Scientific Affairs, LLC
$252
Verrica Pharmaceuticals Inc.
$229
Arcutis Biotherapeutics, Inc.
$183
Amgen Inc.
$172
Incyte Corporation
$171
Dermavant Sciences, Inc.
$161
E.R. Squibb & Sons, L.L.C.
$145
UCB, Inc.
$131
GENZYME CORPORATION
$114
Regeneron Healthcare Solutions, Inc.
$28
SUN PHARMACEUTICAL INDUSTRIES INC.
$23
Daiichi Sankyo Inc.
$20
LEO Pharma Inc.
$20
Top 3 companies account for 52.0% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Biotech, Inc.
$1,440
ABBVIE INC.
$1,230
Amgen Inc.
$592
Dermavant Sciences, Inc.
$580
E.R. Squibb & Sons, L.L.C.
$395
Janssen Scientific Affairs, LLC
$367
Incyte Corporation
$331
Verrica Pharmaceuticals Inc.
$328
GENZYME CORPORATION
$324
Organogenesis Inc.
$256
Arcutis Biotherapeutics, Inc.
$183
UCB, Inc.
$167
Novartis Pharmaceuticals Corporation
$103
AbbVie Inc.
$77
Galderma Laboratories, L.P.
$76
Regeneron Healthcare Solutions, Inc.
$70
Sun Pharmaceutical Industries Inc.
$65
Allergan, Inc.
$32
SUN PHARMACEUTICAL INDUSTRIES INC.
$23
Daiichi Sankyo Inc.
$20
LEO Pharma Inc.
$20
Lilly USA, LLC
$20
Almirall LLC
$15
Top 3 companies account for 48.6% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · BLU-U · Bimzelx · COSENTYX · Cimzia · DUPIXENT · HUMIRA · ILUMYA · INJECTAFER · OPZELURA · Otezla · Puraply · REMICADE · RINVOQ · SKYRIZI · Seysara · Sotyktu · TALTZ · TREMFYA · VTAMA · Winlevi · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for physician assistant in CA.

Looking for a physician assistant in Bakersfield?
Compare physician assistants in the Bakersfield area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
126
Per 100K population
13.8
County median income
$67,660
Nearest hospital
BAKERSFIELD BEHAVIORAL HEALTHCARE HOSPITAL, LLC
14.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Samra is a clinical cardiology specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement in the top 4% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Samra experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Samra performed 803 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Samra receive payments from pharmaceutical companies?
Yes. Dr. Samra received a total of $6,715 from 23 companies across 255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Samra's costs compare to other physician assistants in Bakersfield?
Dr. Samra's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Samra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →